In Vitro Assessment of Chemically Modified Probiotic Bacteria as Receptor-Mimic Decoys for Cholera Toxin B Subunit
- 1DTU Bioengineering, Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, DK-2800 Lyngby, Denmark
Abstract
Gastrointestinal infections remain a major cause of morbidity and mortality worldwide. Conventional antibiotic treatment can be ineffective or inappropriate in some settings, particularly in the context of increasing antimicrobial resistance. In many enteric infections, an early step in pathogenesis involves binding of pathogens or their toxins to oligosaccharide receptors on host–cell surfaces, making these interactions attractive targets for antimicrobial strategies that do not rely on conventional antibiotics. Here, we developed a non-recombinant, microbiome-based chemical engineering approach in which cholesteryl-peptides serve as flexible chemical scaffolds for displaying GM1 receptor mimics on probiotic bacteria. After incubation with the GM1-cholesteryl-peptides, GM1 signals accessible to the cholera toxin B subunit (CTB) were detected on both the Gram-positive probiotic Lactobacillus reuteri DSM 17938 and the Gram-negative probiotic Escherichia coli Nissle 1917. The resulting GM1-decorated bacteria showed concentration-dependent CTB binding and sequestration in vitro and reduced CTB binding to Vero cells. These findings establish an in vitro proof-of-concept for a modular, non-recombinant bacterial decoy platform and may provide a basis for the future development of receptor-mimic strategies against toxin-mediated gastrointestinal infections.
Related
- Assessment of the Safety of a Combined Medicinal Agent Based on Probiotic Lactic Acid Bacteria and the Natural Component Glycyrrhiza glabra
- Physically and chemically modified starches as texturisers of low-fat milk gels
- Probiotic-Enriched Yogurt with Encapsulated Lacticaseibacillus rhamnosus and Bacillus clausii: Product Characterization and Quality of Life Assessment in Type 2 Diabetes
- Interrater Reliability of the Modified Tuck Jump Assessment Scored by Physical Therapy Students
- Identification of a Potential Food Additive Mixture and Health Risk Assessment Using the Modified Reference Point Index (mRPI)
BibTeX
@article{rocca2026vitro,
title = {{In Vitro Assessment of Chemically Modified Probiotic Bacteria as Receptor-Mimic Decoys for Cholera Toxin B Subunit}},
author = {Ilaria Mainero Rocca and Nicolai Stuhr-Hansen and Ola Blixt and Steffen Goletz},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27209290},
url = {https://www.mdpi.com/1422-0067/27/20/9290},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - In Vitro Assessment of Chemically Modified Probiotic Bacteria as Receptor-Mimic Decoys for Cholera Toxin B Subunit
AU - Ilaria Mainero Rocca
AU - Nicolai Stuhr-Hansen
AU - Ola Blixt
AU - Steffen Goletz
PY - 2026
DA - 2026/10/19
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27209290
UR - https://www.mdpi.com/1422-0067/27/20/9290
AB - Gastrointestinal infections remain a major cause of morbidity and mortality worldwide. Conventional antibiotic treatment can be ineffective or inappropriate in some settings, particularly in the context of increasing antimicrobial resistance. In many enteric infections, an early step in pathogenesis involves binding of pathogens or their toxins to oligosaccharide receptors on host–cell surfaces, making these interactions attractive targets for antimicrobial strategies that do not rely on conventional antibiotics. Here, we developed a non-recombinant, microbiome-based chemical engineering approach in which cholesteryl-peptides serve as flexible chemical scaffolds for displaying GM1 receptor mimics on probiotic bacteria. After incubation with the GM1-cholesteryl-peptides, GM1 signals accessible to the cholera toxin B subunit (CTB) were detected on both the Gram-positive probiotic Lactobacillus reuteri DSM 17938 and the Gram-negative probiotic Escherichia coli Nissle 1917. The resulting GM1-decorated bacteria showed concentration-dependent CTB binding and sequestration in vitro and reduced CTB binding to Vero cells. These findings establish an in vitro proof-of-concept for a modular, non-recombinant bacterial decoy platform and may provide a basis for the future development of receptor-mimic strategies against toxin-mediated gastrointestinal infections.
SN - 1422-0067
ER -